Skip to content

Clinical Evaluation of SDF Combined With KI Versus SDF in Management of Class I Carious Lesions

Clinical Evaluation of Silver Diamine Fluoride Combined With Potassium Iodide Versus Silver Diamine Fluoride in Management of Class I Carious Lesions Over a Period of 12 Months Follow-up: A Randomized Controlled Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05485272
Enrollment
42
Registered
2022-08-03
Start date
2022-02-01
Completion date
2023-03-02
Last updated
2022-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carious Lesion

Brief summary

To evaluate the clinical performance of High-Viscosity Glass Ionomer (EQUIA) versus Silver Diamine Fluoride combined with Potassium Iodide (Riva Star) and Sliver Diamine Fluoride (SDF) under High-Viscosity Glass Ionomer (EQUIA) in deep class I carious lesions, over a period of one year follow-up. The null hypothesis tested in this study, that in deep class I carious lesions, the High-Viscosity Glass Ionomer (EQUIA) versus Silver Diamine Fluoride combined with Potassium Iodide (Riva Star) and Sliver Diamine Fluoride (SDF) under High-Viscosity Glass Ionomer (EQUIA) will show the same clinical performance.

Detailed description

A sample of adults with an age range of 18-40 years old, having a permanent molar with deep class I carious lesions, according to the international caries detection and assessment system (ICDAS), occlusal caries that scored 4 (underlying dark shadow from dentin), or 5 (Distinct cavity with visible dentin), will be selected from the patients attending at the Conservative and Esthetic Dentistry Department Clinic, Faculty of Dentistry, Cairo University, and those who meet the study inclusion criteria will be recruited. All selected 42 permanent molars will be randomly equally allocated into three groups according to the material used. Group I (n=14) Silver Diamine Fluoride combined with Potassium Iodide (Riva Star) under High-Viscosity Glass Ionomer (EQUIA), Group II (n=14) Silver Diamine Fluoride (SDF) both under High-Viscosity Glass Ionomer (EQUIA), and Group III (n=14) High-Viscosity Glass Ionomer (EQUIA). Steps in Short: 1. Recruitment of the patients and full examination with diagnosis. 2. Informed consent taking for the eligible participants to participate in the study. 3. Randomization and allocation into three groups. 4. Application of the intervention 1; Silver Diamine Fluoride combined with Potassium Iodide (Riva Star). Intervention 2; Silver Diamine Fluoride (SDF). Both under High-Viscosity Glass Ionomer (EQUIA). The comparator; High-Viscosity Glass Ionomer (EQUIA). All materials were manipulated according to the manufacturers' instructions. 5. Baseline data collection of the clinical evaluation of the restorations using FDI criteria. 6. Follow up at 3, 6, and 12 months for data collection of the clinical evaluation of the restorations using FDI criteria.

Interventions

OTHERSilver Diamine Fluoride combined with Potassium Iodide.

Riva Star, Silver diamine fluoride 38% and potassium iodide, SDI, Bayswater, Australia.

OTHERSilver Diamine Fluoride.

A clear liquid that combines the antibacterial effects of silver and the remineralizing effects of fluoride.

OTHERHigh-Viscosity Glass Ionomer.

A Glass Hybrid material.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

The operator will not be blinded due to differences between both materials.

Intervention model description

A 3-arm randomized clinical trial. Randomization will be done according to a check list including the number of participants divided into 3 groups of 14 patients (42 total) according to interventions/Control assessment methods.

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

1. Patients with deep class I carious lesions in molars, according to the international caries detection and assessment system (ICDAS), occlusal caries that scored 4 (underlying dark shadow from dentin), or 5 (Distinct cavity with visible dentin). 2. Adults males or females. 3. Age: 18-40 years old. 4. Good Oral hygiene. 5. Co-operative patients, approving to participate in the study. 6. Teeth planned to be restored should be vital. 7. Presence of favorable occlusion.

Exclusion criteria

1. Patients having severe systemic diseases, allergies, or adverse medical histories. 2. Patients complaining of sever or active periodontal disease. 3. Lack of compliance. 4. Teeth diagnosed with irreversible pulpitis. 5. Non vital teeth. 6. Heavy occlusion.

Design outcomes

Primary

MeasureTime frameDescription
Biological Properties: (Postoperative hyper-sensitivity)12 Months.will be ranked according to Federation Dentaire Internationale criteria (FDI). Scoring system (1,2,3,4,5) by patient interviewing

Secondary

MeasureTime frameDescription
Functional Properties: (Radiographic examination and Patient's view) (Radiographic examination, and Patient's view)12 months.will be ranked according to Federation Dentaire Internationale criteria (FDI). Scoring system (1,2,3,4,5) by standardized periapical digital radiographs taken by parallel technique and by patient interviewing
Esthetic: Tooth Color12 months.by Easy Shade. measuring unit: ΔE

Countries

Egypt

Contacts

Primary ContactShorouk H Helmy, Master's
shorouk.helmy@dentistry.cu.edu.eg00201015775110

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026